CClinicalTrials.gg
CompletedNCT05572294Updated Feb 13, 2023

Mindfulness and Yoga Therapy for Acute Pain in Sickle Cell Disease

An interventional study of Mindfulness meditation, breathing exercises (including incentive spirometry), and yoga therapy in Sickle Cell Crisis and Sickle Cell Disease, sponsored by University of Texas Southwestern Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-02-13.

Sponsored by University of Texas Southwestern Medical Center · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
39
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Patients with sickle cell disease suffer from acute and chronic pain that diminishes their quality of life. The purpose of this study is to assess the feasibility and acceptability of mindfulness meditation, breathing exercises, and gentle yoga therapy as supportive measures for the management of acute vaso-occlusive pain crises in the inpatient setting.

Read the detailed description

This is a prospective single arm study of mindfulness interventions for sickle cell patients admitted with an acute vaso-occlusive pain crisis. Patients will be accrued over a consecutive 12 week period. All genotypes of sickle cell disease will be eligible for enrollment.

After providing informed consent, the patients will have access to 4 videos on their hospital room television. The videos contain guided mindfulness meditation, breathing exercises (including the use of an incentive spirometer), and gentle yoga therapy that can be performed in the supine position from a hospital bed. Videos vary in length from 5-12 minutes. Participants will have the ability to watch the videos as many times as they choose. They may also turn off the video at any time.

The primary outcome is feasibility and acceptability of the intervention. We will record objective data on how many videos are watched by each participant, as well as the percentage of each video completed. We will obtain information about the participants' perception of the intervention through a post-intervention survey and interview.

02

Conditions studied

  • Sickle Cell Crisis
  • Sickle Cell Disease

Keywords

  • Sickle Cell Disease
  • Yoga Therapy
  • Mindfulness
03

In context

Anemia, Sickle Cell

1,103 studies on the registry are indexed under Anemia, Sickle Cell; 235 are open to participants now.

This study's enrollment of 39 is close to the median of 40 across 750 interventional studies indexed under Anemia, Sickle Cell.

Browse Anemia, Sickle Cell studies →

Lead sponsor

University of Texas Southwestern Medical Center is the lead sponsor of 990 studies on the registry; 201 are open to participants now.

Of its 135 completed or terminated interventional studies of FDA-regulated products, 100 (74%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients with sickle cell disease, any genotype
  • Adult patients at least 18 years of age
  • English speaking
  • Admitted to Clements University Hospital with an acute vaso-occlusive pain crisis

Exclusion criteria

Exclusion criteria:

  • Unable to follow simple instructions
  • Admitted to the intensive care unit
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
39 participants (actual)

Study arms

  • Experimental
    Mindfulness and Yoga Therapy

    Participants will have access to video-guided mindfulness interventions.

    Behavioral: Mindfulness meditation, breathing exercises (including incentive spirometry), and yoga therapy

Interventions

  • BehavioralMindfulness meditation, breathing exercises (including incentive spirometry), and yoga therapy

    Sickle cell patients admitted with a vaso-occlusive pain crisis over a consecutive 12-week period will be offered participation in the study. After providing informed consent, participants will have access to 4 videos containing guided mindfulness meditation, breathing exercises, and gentle yoga therapy. The videos are 5-12 minutes long and taught by a physical therapist who is also certified in yoga therapy. Participants may turn off the video at any time. Participants will have access to the videos for the duration of their hospitalization, and they may watch the videos as many times as they desire.

06

What researchers measure

Primary outcomes

  1. Feasibility of the intervention as measured by the proportion of sickle cell patients admitted over a consecutive 12 week time period who agree to participate in the study

    Time frame: 12 weeks

  2. Feasibility of the intervention as measured by the proportion of participants who accessed the mindfulness videos during their hospitalization

    Time frame: 12 weeks

  3. Acceptability of the intervention as measured by the proportion of participants who found the mindfulness practices enjoyable and/or helpful

    This data will be collected via a post-intervention survey and interview. The survey will contain simple questions with yes/no answer options. The interview will be conducted by a study member, either in-person or by telephone.

    Time frame: at the time of hospital discharge, up to 6 months post-intervention

  4. Acceptability of the intervention as measured by the proportion of participants who are interested in pursuing mindfulness therapies in the future

    This data will be collected via a post-intervention survey and interview. The survey will contain simple questions with yes/no answer options. The interview will be conducted by a study member, either in-person or by telephone.

    Time frame: at the time of hospital discharge, up to 6 months post-intervention

  5. Participant engagement as measured by the number of mindfulness videos watched by each participant during their hospitalization

    Time frame: at the time of hospital discharge, up to 6 months post-intervention

  6. Participant engagement as measured by the percentage of videos completed. A video is considered completed if the participant watches more than 85% of the video.

    Time frame: at the time of hospital discharge, up to 6 months post-intervention

07

Study locations

1 site
  • University of Texas Southwestern Medical Center
    Dallas, Texas 75390, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05572294
Lead sponsor
University of Texas Southwestern Medical Center
Responsible party
Siayareh Rambally (Associate Professor, University of Texas Southwestern Medical Center) — Principal investigator
First posted
Oct 7, 2022
Start date
Nov 10, 2022
Primary completion
Feb 2, 2023
Completion
Feb 2, 2023
Last update
Feb 13, 2023

Study contacts

Siayareh Rambally, M.D.
principal investigator · University of Texas Southwestern Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion